Published in Biochemistry on June 20, 2000
The evolution of enzyme specificity in Fasciola spp. J Mol Evol (2003) 0.99
Squamous cell carcinoma antigen 1 promotes caspase-8-mediated apoptosis in response to endoplasmic reticulum stress while inhibiting necrosis induced by lysosomal injury. Mol Cell Biol (2011) 0.93
The Spn4 gene from Drosophila melanogaster is a multipurpose defence tool directed against proteases from three different peptidase families. Biochem J (2007) 0.88
Multiple domains of endopin 2A for serpin cross-class inhibition of papain. Arch Biochem Biophys (2007) 0.80
Adaptive evolution and divergence of SERPINB3: a young duplicate in great Apes. PLoS One (2014) 0.75
Isolation of single-copy human genes from a library of yeast artificial chromosome clones. Science (1989) 5.29
The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem (2001) 4.81
Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science (1996) 4.22
Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest (2000) 4.16
Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med (1998) 3.83
Regulation of integrin function by the urokinase receptor. Science (1996) 3.56
Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res (2000) 3.55
Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest (1998) 3.17
Emerging roles for cysteine proteases in human biology. Annu Rev Physiol (1997) 3.05
Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med (1990) 3.04
Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity (1999) 3.01
Macrophage tumor killing: influence of the local environment. Science (1977) 2.94
Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity (1996) 2.93
Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease. Structure (2000) 2.92
Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem (1994) 2.92
Vinyl sulfones as mechanism-based cysteine protease inhibitors. J Med Chem (1995) 2.70
Characterization of the effects of endotoxin on macrophage tumor cell killing. J Immunol (1978) 2.65
A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol (1999) 2.46
Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med (2000) 2.36
Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 2.20
Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J Biol Chem (1992) 2.13
Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Mol Biol Cell (2001) 2.09
Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest (1999) 2.03
Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ (2003) 1.91
Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol (1983) 1.88
Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J (1998) 1.85
Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor. Cell (1982) 1.84
Cathepsin K--a marker of macrophage differentiation? J Pathol (2001) 1.77
Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest (1998) 1.76
Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med (1998) 1.75
Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci U S A (1993) 1.73
Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation. J Clin Invest (1984) 1.72
Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood (1986) 1.60
Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. J Cell Biol (1999) 1.58
Protein structural alignments and functional genomics. Proteins (2001) 1.57
Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. Biochemistry (1998) 1.56
Cathepsins and compartmentalization in antigen presentation. Curr Opin Immunol (2000) 1.55
Proteases involved in MHC class II antigen presentation. Immunol Rev (1999) 1.54
Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood (1996) 1.52
Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ Res (2003) 1.51
Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J Biol Chem (1994) 1.49
Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J Exp Med (2000) 1.49
Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J Clin Invest (1997) 1.49
Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. Blood (1991) 1.48
Elastinolytic activity of human cathepsin L. Biochem J (1986) 1.48
DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation. J Biol Chem (2001) 1.47
A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci U S A (1995) 1.47
Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol (1998) 1.47
Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cell Mol Life Sci (2004) 1.46
The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics (1994) 1.46
Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett (1995) 1.42
Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. Biochem J (1989) 1.42
Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Mol Biochem Parasitol (1992) 1.39
Glycoprotein Ib-IX-V. Int J Biochem Cell Biol (2003) 1.38
A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. J Biol Chem (1991) 1.38
Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J Biol Chem (1997) 1.37
Modulation of macrophage tumoricidal capability by components of normal serum: a central role for lipid. Science (1977) 1.35
Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest (1993) 1.35
Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J Exp Med (2000) 1.35
Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. Biochemistry (2000) 1.34
Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K. Blood (2000) 1.33
Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am Rev Respir Dis (1986) 1.33
alpha 1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. J Biol Chem (1995) 1.33
Group theory implications for changing health patterns. Am J Public Health Nations Health (1969) 1.33
Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids. J Biol Chem (1998) 1.32
IFI60/ISG60/IFIT4, a new member of the human IFI54/IFIT2 family of interferon-stimulated genes. Genomics (1998) 1.31
Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem (1994) 1.30
Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J Biol Chem (1995) 1.30
Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice. Br J Pharmacol (2008) 1.29
Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S. Immunity (2001) 1.29
The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site. J Mol Biol (1997) 1.27
Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function. J Biol Chem (2000) 1.26
Intramolecularly quenched fluorogenic tetrapeptide substrates for tissue and plasma kallikreins. Anal Biochem (1991) 1.25
Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J Exp Med (1997) 1.25
An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J Clin Invest (1991) 1.23
Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest (1999) 1.23
Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme. Biochemistry (2000) 1.20
Co-operation between plasmin and elastase in elastin degradation by intact murine macrophages. Biochem J (1984) 1.19
Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation. Am J Pathol (2001) 1.18
Cleaved antitrypsin polymers at atomic resolution. Protein Sci (2000) 1.17
Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Biochemistry (1997) 1.16
Comparison of live human neutrophil and alveolar macrophage elastolytic activity in vitro. Relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors. J Clin Invest (1984) 1.16
Biochemical characterization of human cathepsin X revealed that the enzyme is an exopeptidase, acting as carboxymonopeptidase or carboxydipeptidase. Eur J Biochem (2000) 1.15
The macrophage as an antineoplastic surveillance cell: biological perspectives. J Reticuloendothel Soc (1978) 1.15
Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease. J Clin Invest (1985) 1.15